Moteur de recherche d’entreprises européennes
Financement de l’UE (1 778 325 €) : Imagerie 4D à haut débit pour les études cellulaires à l’échelle nanométrique Hor 07/10/2019 Programme de recherche et d'innovation de l'UE « Horizon »
Vue d’ensemble
Texte
Imagerie 4D à haut débit pour les études cellulaires à l’échelle nanométrique
Fluorescence microscopy is an invaluable tool for exploring the structure and function of biological processes. It provides high specificity and contrast for the observation of cellular components tagged with fluorescent molecules in a minimally invasive fashion, allowing the study of live specimens. Furthermore, the development of super resolution (SR) fluorescence microscopy has unlocked the access to spatial resolutions beyond the diffraction limit of visible light (~250nm), fuelling the discovery of new biological structures and dynamics. Nevertheless, achieving resolutions below ~10nm is challenged by multiple trade-offs between spatial and temporal resolutions, depth of observation and photo toxicity, making it difficult or impossible to obtain a molecular resolution. Additionally, axial resolutions are inevitably poorer than lateral ones, unless utilizing a complex multi-objective lens approach. I recently developed MINFLUX, a localization technique that merges concepts of SR with information theory. It achieves isotropic nanometer resolution in three dimensions with a single objective lens and has unrivaled spatio temporal resolution. However, a platform that enables these capabilities in a high-throughput manner for entire cells and tissue has not yet been developed. I aim to fill this technological gap; with my background and experience, I am in a unique position to assure the success of this project and establish these technologies in the scientific community. The performance of fluorescence imaging and tracking will progress orders of magnitude in the years to come, signaling yet another revolution for optical nanoscopy.
| Forschungsinstitut FUR Molekulare Pathologie GmbH | 1 778 325 € |
https://cordis.europa.eu/project/id/853348
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : Forschungsinstitut für molekulare Pathologie GmbH, Vienne, Autriche.